Equity Research Database

Institutional Investment Pitches

Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.

Conestoga Mid Cap Composite's investment thesis on IDEXX Laboratories, Inc. ($IDXX) — Q2 2025 | Buyside Digest

$IDXXNASDAQIDEXX Laboratories, Inc.

BULL

Conestoga Mid Cap Composite—IDXX

Fund Letter

Q2 2025

Published June 30, 2025

$554.99USD

+3.7% vs last month

$547.01Pitched

+1.5% since pitch

Market Cap$46.1B

P/E (TTM)N/A

52-Wk RangeN/A

Div. YieldN/A

Conestoga's Small Cap Growth Composite returned 4.76% net in 2Q25, underperforming the Russell 2000 Growth Index's 11.97% return. The quarter was...

— Conestoga Capital Advisors, LLC

BSD Research Exclusive

Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($55/mo) and Pro subscribers.

6,000+ Institutional Pitches

Proprietary AI Analysis

100 Letter Unlocks/Cycle

Already a Research or Pro subscriber? Sign In

◆ Keep Reading

Other investors who've written on IDEXX Laboratories, Inc.

No other institutional pitches found for this ticker yet.